Furofushi Research Partners with Yuurea for Data-Driven Health Solutions
Key facts
- Furofushi Research Partners with Yuurea for Data-Driven Health Solutions
- Furofushi Research and Yuurea have entered into a business partnership. They will collaborate on research to build health management solutions based on bio-data, leveraging Yuurea's urine analysis technology to provide scientific evidence for supplement efficacy.
- Source: PR Times
- Date: June 8, 2026
Direct answer
Furofushi Research and Yuurea have entered into a business partnership. They will collaborate on research to build health management solutions based on bio-data, leveraging Yuurea's urine analysis technology to provide scientific evidence for supplement efficacy.
- Citation
- Furofushi Research Partners with Yuurea for Data-Driven Health Solutions (June 8, 2026), PR Times
- Source
- PR Times
- Date
- June 8, 2026
Furofushi Research and Yuurea have entered into a business partnership. They will collaborate on research to build health management solutions based on bio-data, leveraging Yuurea's urine analysis technology to provide scientific evidence for supplement efficacy.
📋 Article Processing Timeline
- 📰 Published: June 8, 2026 at 19:00
- 🔍 Collected: June 8, 2026 at 10:26
- 🤖 AI Analyzed: June 8, 2026 at 10:35 (9 min after Collected)
Background: From Subjectivity to Data-Driven Design
Based on the philosophy of realizing a world where everyone can smile and shine throughout their lives, the institute views health as life's greatest asset and pursues the extension of "healthspan."
Believing that maintaining daily conditions is the driving force behind a vibrant life, the institute uses high-purity "Reduced Coenzyme Q10" from Kaneka Corporation and "Assist NMN" from Kobayashi Perfumery. The institute supports those who wish to maintain vitality and youthfulness from within.
By adding objective data to the subjective "experience" and "sense of security" provided by supplements, health management can evolve. Through this partnership, they will utilize Yuurea's unique instant urine analysis technology to capture "changes in physical conditions" as objective bio-data. By combining their products with this technology, they aim to transition health management from "feeling-based" to "data-driven design."
Specific Initiatives
1. Personalized Recommendations and Collaborative Research using Bio-data
By introducing urine testing kits and a dedicated app, they will create an environment that supports optimal intake habits based on individual measurement data. They will also conduct collaborative research on recording conditions before and after supplement intake to refine product design and build scientific evidence. (Analysis data will be anonymized and strictly managed.)
2. Joint Development of Next-Generation Healthcare Solutions
Looking ahead, they plan to strengthen their long-term partnership with an eye toward co-developing new testing kits that fuse both companies' technologies. They aim to "democratize health management" and create a society where everyone can proactively optimize their own condition.
FAQ
What is the purpose of the collaboration between the Institute of Immortality and Yuria?
The purpose is to integrate both companies' technologies to provide health management solutions based on biodata, enhance product design, and build evidence.
What kind of joint research will be conducted?
By using urine test kits and an app to record and analyze changes before and after supplement intake, we aim to enhance product design based on objective data and build evidence.
What are the future goals?
We aim to develop new test kits by integrating both companies' expertise, promote democratization of health management, and realize a society where everyone can optimize their condition proactively.
What are the characteristics of the products handled by the Institute of Immortality?
The Institute offers supplements that use Kaneka's domestically produced 'reduced Coenzyme Q10' and Kobayashi Fragrance's high-purity 'Assist NMN'.
What are Yuria's main businesses?
Yuria develops and sells the urine testing service 'Yuurea', conducts research and development using biomarkers, and provides healthcare apps.